Skip to content
PreclinicalResearch compoundLimited evidence

Baicalin

Baikal skullcap flavone glucuronide with GABA-A-modulating anxiolytic action.

AnxiolyticFlavonoidAnxiolyticMoodGABAnoo.affects.anti-inflammatorynoo.affects.mood

Pharmacology

ClassAnxiolytic · Mood
Primary targetGABA-A receptor positive allosteric modulation (α2/α3 preference)
Targets4 receptor targets
Half-lifeNot well characterized; depends on interconversion with baicalein
OnsetNo well-characterized human data (absorption is slow and variable)
EvidenceLimited evidence
Affected systemsGABAnoo.affects.anti-inflammatorynoo.affects.mood

Contents

WHAT IS BAICALIN?

Detailed overview

Baicalin is a flavone glucuronide, the main active compound of the root of Baikal skullcap (Scutellaria baicalensis), formed as the 7-O-glucuronide conjugate of the aglycone baicalein. In animal studies it shows anxiolytic and mildly sedative effects: it acts as a positive allosteric modulator of the GABA-A receptor, preferring the α2/α3 subunits at a benzodiazepine-independent site, and therefore reduces anxiety without the drowsiness and muscle relaxation typical of conventional benzodiazepines. It is also a potent antioxidant and NF-κB-inhibiting anti-inflammatory. Its main limitation is poor oral absorption and low bioavailability, and human clinical data are sparse.

Mechanism

GABA-A PAM (α2/α3) + anti-inflammatory

Evidence

Preclinical (animal studies)

Legal status

Dietary supplement / botanical extract

Receptor profile

  • GABA-A receptors (α2/α3 subunit)Moderate
  • NF-κB inflammatory pathwayModerate
  • Oxidative stress / antioxidant actionModerate
  • Benzodiazepine-independent GABAergic siteWeak

Safety

Side effects, stop signs, contraindications

Side effects · 5

  • Poor oral absorption and low bioavailability limit the effect
  • May potentiate sedative and anxiolytic drugs through GABA-A interaction
  • Gastrointestinal upset (nausea, diarrhea) at higher doses
  • Incomplete human safety profile: mostly animal-derived data
  • Theoretical interaction with drugs metabolized by cytochrome P450 and UGT enzymes

Contraindications · 4

  • Pregnancy and breastfeeding: safety not established, avoid
  • Concurrent use of sedatives, benzodiazepines or alcohol: additive sedation
  • Avoid before surgery due to possible GABAergic and clotting effects
  • Not a medicine; a plant flavonoid sold as a supplement, medical supervision advised in chronic illness

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Baikal skullcap flavone glucuronide with GABA-A-modulating anxiolytic action.

Telegram

Have a question about Baicalin?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeAnxiolytic
FormulaC21H18O11
UpdatedJuly 10, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: July 10, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.